Skip to content

CELLULAR BIOMEDICINE GROUP, INC.

CIK 0001378624

← back to feed
Revenue (TTM)
$32.3K
Q3 Nov 2020
Net Income (TTM)
−$57.98M
+20.0% YoY Q3 Nov 2020
EPS Diluted (TTM)
−$1.80
−11.6% YoY Q3 Nov 2020
Gross Margin
10,057.0%
Q3 Nov 2020
Operating Margin
-182,617.7%
Q3 Nov 2020
Net Margin
-179,537.1%
Q3 Nov 2020
Free Cash Flow (TTM)
—
Q3 Nov 2020
Cash
$26.03M
Q3 Nov 2020
Total Debt
$47.87M
Q3 Nov 2020
Shares Outstanding
19.46M sh
Q3 Nov 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings